Invention Grant
- Patent Title: ExPEC glycoconjugate vaccine formulations
-
Application No.: US16191659Application Date: 2018-11-15
-
Publication No.: US10525145B2Publication Date: 2020-01-07
- Inventor: Olga Labovitiadi , Wouter Frank Tonnis , Francesco Doro , Janik Adriaansen
- Applicant: Janssen Pharmaceuticals, Inc.
- Applicant Address: US NJ Titusville
- Assignee: Janssen Pharmaceuticals, Inc.
- Current Assignee: Janssen Pharmaceuticals, Inc.
- Current Assignee Address: US NJ Titusville
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: EP16195256 20161024
- Main IPC: A61K47/64
- IPC: A61K47/64 ; A61K39/108 ; A61K47/02 ; A61K47/20 ; A61K47/26 ; C08B37/00 ; A61K47/65 ; A61K39/00
Abstract:
Compositions and methods for inducing an immune response against extra-intestinal pathogenic Escherichia coli (ExPEC) are described. In particular, multivalent vaccines containing E. coli antigen polysaccharide covalently bound to a exotoxin A of Pseudomonas aeruginosa (EPA) carrier protein that can withstand multiple environmental stresses are described.
Public/Granted literature
- US20190105402A1 ExPEC GLYCOCONJUGATE VACCINE FORMULATIONS Public/Granted day:2019-04-11
Information query
IPC分类:
